163 related articles for article (PubMed ID: 23010496)
1. In vivo redox state of human thioredoxin and redox shift by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA).
Ungerstedt J; Du Y; Zhang H; Nair D; Holmgren A
Free Radic Biol Med; 2012 Dec; 53(11):2002-7. PubMed ID: 23010496
[TBL] [Abstract][Full Text] [Related]
2. Suberoylanilide hydroxamic acid induces thioredoxin1-mediated apoptosis in lung cancer cells via up-regulation of miR-129-5p.
You BR; Park WH
Mol Carcinog; 2017 Dec; 56(12):2566-2577. PubMed ID: 28667779
[TBL] [Abstract][Full Text] [Related]
3. Suberoylanilide hydroxamic acid-induced HeLa cell death is closely correlated with oxidative stress and thioredoxin 1 levels.
You BR; Park WH
Int J Oncol; 2014 May; 44(5):1745-55. PubMed ID: 24626405
[TBL] [Abstract][Full Text] [Related]
4. The levels of HDAC1 and thioredoxin1 are related to the death of mesothelioma cells by suberoylanilide hydroxamic acid.
You BR; Park WH
Int J Oncol; 2016 May; 48(5):2197-204. PubMed ID: 26936390
[TBL] [Abstract][Full Text] [Related]
5. Oxidation of structural cysteine residues in thioredoxin 1 by aromatic arsenicals enhances cancer cell cytotoxicity caused by the inhibition of thioredoxin reductase 1.
Zhang X; Lu J; Ren X; Du Y; Zheng Y; Ioannou PV; Holmgren A
Free Radic Biol Med; 2015 Dec; 89():192-200. PubMed ID: 26169724
[TBL] [Abstract][Full Text] [Related]
6. Differential oxidation of thioredoxin-1, thioredoxin-2, and glutathione by metal ions.
Hansen JM; Zhang H; Jones DP
Free Radic Biol Med; 2006 Jan; 40(1):138-45. PubMed ID: 16337887
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic effects of Jay Amin hydroxamic acid (JAHA), a ferrocene-based class I histone deacetylase inhibitor, on triple-negative MDA-MB231 breast cancer cells.
Librizzi M; Longo A; Chiarelli R; Amin J; Spencer J; Luparello C
Chem Res Toxicol; 2012 Nov; 25(11):2608-16. PubMed ID: 23094795
[TBL] [Abstract][Full Text] [Related]
8. Redox status of thioredoxin-1 (TRX1) determines the sensitivity of human liver carcinoma cells (HepG2) to arsenic trioxide-induced cell death.
Tian C; Gao P; Zheng Y; Yue W; Wang X; Jin H; Chen Q
Cell Res; 2008 Apr; 18(4):458-71. PubMed ID: 18157160
[TBL] [Abstract][Full Text] [Related]
9. Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in mantle cell lymphoma.
Heider U; von Metzler I; Kaiser M; Rosche M; Sterz J; Rötzer S; Rademacher J; Jakob C; Fleissner C; Kuckelkorn U; Kloetzel PM; Sezer O
Eur J Haematol; 2008 Feb; 80(2):133-42. PubMed ID: 18005386
[TBL] [Abstract][Full Text] [Related]
10. Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites.
Huang L; Sowa Y; Sakai T; Pardee AB
Oncogene; 2000 Nov; 19(50):5712-9. PubMed ID: 11126357
[TBL] [Abstract][Full Text] [Related]
11. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances taxol-induced cell death in breast cancer.
Shi YK; Li ZH; Han XQ; Yi JH; Wang ZH; Hou JL; Feng CR; Fang QH; Wang HH; Zhang PF; Wang FS; Shen J; Wang P
Cancer Chemother Pharmacol; 2010 Nov; 66(6):1131-40. PubMed ID: 20838997
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibitor suberoylanilide hydroxamic acid suppresses the pro-oncogenic effects induced by hepatitis B virus pre-S2 mutant oncoprotein and represents a potential chemopreventive agent in high-risk chronic HBV patients.
Hsieh YH; Su IJ; Yen CJ; Tsai TF; Tsai HW; Tsai HN; Huang YJ; Chen YY; Ai YL; Kao LY; Hsieh WC; Wu HC; Huang W
Carcinogenesis; 2013 Feb; 34(2):475-85. PubMed ID: 23172669
[TBL] [Abstract][Full Text] [Related]
13. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor: effects on gene expression and growth of glioma cells in vitro and in vivo.
Yin D; Ong JM; Hu J; Desmond JC; Kawamata N; Konda BM; Black KL; Koeffler HP
Clin Cancer Res; 2007 Feb; 13(3):1045-52. PubMed ID: 17289901
[TBL] [Abstract][Full Text] [Related]
14. Chemosensitization of oral squamous cell carcinoma cells to cisplatin by histone deacetylase inhibitor, suberoylanilide hydroxamic acid.
Rikiishi H; Shinohara F; Sato T; Sato Y; Suzuki M; Echigo S
Int J Oncol; 2007 May; 30(5):1181-8. PubMed ID: 17390020
[TBL] [Abstract][Full Text] [Related]
15. Reactive oxygen species, glutathione, and thioredoxin influence suberoyl bishydroxamic acid-induced apoptosis in A549 lung cancer cells.
You BR; Kim SH; Park WH
Tumour Biol; 2015 May; 36(5):3429-39. PubMed ID: 25537089
[TBL] [Abstract][Full Text] [Related]
16. Proteasome inhibition sensitizes non-small cell lung cancer to histone deacetylase inhibitor-induced apoptosis through the generation of reactive oxygen species.
Denlinger CE; Rundall BK; Jones DR
J Thorac Cardiovasc Surg; 2004 Nov; 128(5):740-8. PubMed ID: 15514602
[TBL] [Abstract][Full Text] [Related]
17. Combined effects of sulindac and suberoylanilide hydroxamic acid on apoptosis induction in human lung cancer cells.
Seo SK; Jin HO; Lee HC; Woo SH; Kim ES; Yoo DH; Lee SJ; An S; Rhee CH; Hong SI; Choe TB; Park IC
Mol Pharmacol; 2008 Mar; 73(3):1005-12. PubMed ID: 18156316
[TBL] [Abstract][Full Text] [Related]
18. Increasing discordant antioxidant protein levels and enzymatic activities contribute to increasing redox imbalance observed during human prostate cancer progression.
Chaiswing L; Zhong W; Oberley TD
Free Radic Biol Med; 2014 Feb; 67():342-52. PubMed ID: 24269899
[TBL] [Abstract][Full Text] [Related]
19. Redox regulation of actin by thioredoxin-1 is mediated by the interaction of the proteins via cysteine 62.
Wang X; Ling S; Zhao D; Sun Q; Li Q; Wu F; Nie J; Qu L; Wang B; Shen X; Bai Y; Li Y; Li Y
Antioxid Redox Signal; 2010 Sep; 13(5):565-73. PubMed ID: 20218863
[TBL] [Abstract][Full Text] [Related]
20. Modulation of radiation response by histone deacetylase inhibition.
Chinnaiyan P; Vallabhaneni G; Armstrong E; Huang SM; Harari PM
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):223-9. PubMed ID: 15850925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
